Biohaven Ltd. downgraded after FDA CRL for troriluzole; see its pipeline shift to obesity/neurology, Phase 2 catalysts, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results